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Reflux esophagitis is a cause of substantial morbidity in the general 
population. Much effort has been spent in an attempt to elucidate the patho¬ 
physiology of gastroesophagea1 reflux so that a more rational management 
of this disease process may be developed. 
The first portion of this study summarizes the degree to which reflux 
esophagitis is understood. The normal esophagus is described as well as the 
changes which occur as a result of reflux esophagitis. The many factors 
responsible for the development of and/or degree of severity of the resulting 
esophagitis are then analyzed. 
Because the bulk of this study concerns the role of the lower esophageal 
sphincter in reflux esophagitis, special attention has been directed to ex¬ 
plain its function both in the normal subject as well as the patients with 
esophagitis. The role of various prostaglandins in mediating changes in the 
lower esophageal sphincter is also discussed. 
The second, and most important portion of this work, is devoted to an 
explanation of the changes that occur in the smooth muscle of the feline lower 
esophageal sphincter during experimentally induced esophagitis. An animal 
model of acute esophagitis was developed to yield tissue which could be 
subjected to different environments in vitro to determine various smooth 
muscle characteristics. A comparison of the smooth muscle characteristics 
in various areas of the normal distal esophagus including the lower esophageal 
sphincter is made. These findings are then contrasted with those found in 
cats with experimentally induced esophagitis. A discussion of the results 
follows and various hypotheses involving the role of the lower esophageal 




Histology of the Normal Esophagus 
Normally, esophageal mucosa is comprised of a stratified squamous epi¬ 
thelium, a lamina propria, and a muscularis mucosae. The squamous epithelial 
layer is divided into a basal zone which is responsible for the cellular 
proliferation of this layer, and an upper stratified zone whose surface lines 
the lumen of the esophagus. 
The lamina propria is comprised of loose vascular connective tissue with 
lymphocytes, plasma cells, and lymph follicles. Papillae from the lamina 
propria extend into and between the rete pegs of the squamous layer. Under 
this lies the muscularis mucosae, separating the mucosa from the submucosal 
The muscularis mucosae of the esophagus is the thickest layer of smooth 
muscle found in the body. The fibers are arranged longitudinally. 
The remainder of the esophagus is comprised of three accessory coats; 
the submucosa, muscularis, and adventitia. The submucosa is a fibro-e1 astic 
layer containing 60 to 7^0 mucus producing esophageal glands, located mainly 
in the proximal half of the esophagus. The muscularis is composed of an inner 
circular layer and an outer longitudinal layer. Its composition varies and 
may be roughly divided into a proximal quarter which consists of skeletal 
muscle, a middle portion consisting of both skeletal and smooth muscle, and 
a distal third consisting of regularly arranged smooth muscle. The adventitia 
is loose and fibrous and connects with surrounding structures, conducting 
vessels and nerves. Only that portion of the esophagus distal to the diaphragm 
is covered by a serosa. 
Histological Changes in Esophagitis 
Various criteria of the changes created by gastroesophageal reflux have 
1 
been proposed. Those listed below are those of Ismai1-Beigi, et al: 

1) 
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Basal cell hyperplasia. The basal zone increases in thickness such 
that it exceeds its normal 15% of the total thickness of the squamous 
epithelial 1ayer. 
2) Elongation and increased vascularity of the papillae of the lamina 
propria. The papillae extend through more than the normal two-thirds 
of the thickness of the squamous layer. 
3) Leucocytic infiltration of both the lamina propria and the squamous layer 
by neutrophils.' Many explanations for these histological changes have 
been proposed. Livstone, et al were able to suggest an increased cell 
turnover as the mechanism for basal zone hyperplasia. Their studies 
show that the amount of (3h)~thymidine uptake by the mucosa is directly 
2 
proportional to the severity of the changes discussed above. 
All these histological changes are reversible and are secondary to a 
variety of determining factors which follow. Persistence of the determinants 
of esophagitis may lead to erosion of the epithelium, ulceration, chronic in¬ 
flammatory cellular infiltration, fibrosis, and gastric metaplasia. Deep 
ulceration is followed by irreversible fibrosis. Stricture formation may 
ensue. 
Determining Factors in Reflux Esophagitis 
There are many factors responsible for the development of reflux esopha¬ 
gitis. Dodds, et al classifies these determinants of esophagitis with respect 
to competency of the anti-reflux mechanism, potency and volume of refluxed 
3 
material, esophageal emptying and tissue resistance. 
Role of LES in Anti-Reflux Mechanism 
The lower esophageal sphincter (LES) is probably the most important factor 
determining competency of the anti-reflux mechanism. "All that is needed for 
heartburn, please... is lower esophageal sphincter without squeeze.The 
LES is not morphologically identifiable in man, but may be clearly recognized 

in other mammals, such as the bat, which spends much time in an inverted 
k 
position. In man, the LF.S is identifiable, however, by manometry, response 
to various drugs and hormones, and by characteristic force generation in 
response to stretch in vitro.^ DeCarle in 1975 created gastroesophageal 
reflux and resulting esophagitis in the Australian bush possum by a sphincter¬ 
oplasty, temporarily destroying the LES. The LES returned to normal function 
in 10 weeks with corresponding resolution of the esophagitis/* 
The role of the LES in prevention of reflux is mu 11ifactoria 1. The LES 
maintains a resting pressure that is higher than in other areas of the esopha¬ 
gus or stomach. It relaxes during a swallow, permitting passage of a food 
bolus, and then maintains a sustained contraction, gradually relaxing again 
to its resting pressure. Patients with symptoms of reflux esophagitis have 
£ 
lower resting LES pressures than normal subjects. The LES responds to a 
variety of reflux creating stimuli by increasing tone. Lind, et al showed that 
an increase in intra-abdominal pressure in man caused an increase in LES 
pressure greater than that expected due to mechanical impingement.^ This 
LES response to increased intra-abdominal pressure has been found to be de¬ 
fective in patients with reflux esophagitis.^ 
LES function reflects levels of various enteric hormones as well as 
cholinergic and other agents. Gastrin had once been implicated as a major de¬ 
terminant of resting LES pressure. When given in pharmacological dosage, 
8 
gastrin increases LES pressure. No correlation has been found, however, 
between basal serum levels of gastrin and LES pressures, either in normal 
subjects, or in patients with reflux esophagitis.^* In addition, other 
studies have shown that pernicious anemia and the Zo11inger-E11ison syndrome 
are not associated with increased LES pressures although there are very high Z, 
serum gastrin levels found in these diseases. 
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Other hormones m3 y also play 3 role in LES function. The decrease in LES 
pressure after a fatty meal is most likely secondary to hormonal influence. 
Secretin, cho1ecystokinin, and glucagon have all been shown to decrease LES 
pressure.^ Prostaglandins may have some role in regulation of LES pressure 
and are discussed in detail later. Goyal and Rattan have shown that prosta¬ 
glandin F2a increases LES pressure while prostaglandin E2 decreases LES 
9 
pressure in man. 
Neural influences have also been proposed as major determinants of LES 
pressure. Excitatory vagal cholinergic nerves and alpha adrenergic neuro- 
transmittors have been implicated as increasing LES tone, while relaxation has 
been elicited by non-cholinergic, non-adrenergic vagal fibers, called 
■3 
"plir i nerg i c" nerves as well as by beta adrenergic neu rot ransmi t tors . 
Reduction in LES tone in man occurs in certain disorders which damage vagal 
A 
trunk nerve fibers such as diabetic neuropathy. Electrical stimulation 
10 
of the vagus in the opossum produces LES relaxation. 
The amount of smooth muscle present is a factor in the production of LES 
pressure. In a study regarding age-related changes of the LES in the rat, 
Biancani, et al reported that a large increase in the active force generated 
by the LES occurred between the third and sixth weeks of 1ife.^ They attri¬ 
buted this increase to a slight increase in muscle contractility as well as 
by a more than threefold increase in the amount of circular muscle present. 
Further increase in muscle mass with age was not as readily paralleled by 
increasing LES contractility indicating the existence of other factors such as 
1 1 
those being noted. 
In addition to the above factors, there are additional determinants of 
LES pressure, some of which have been indirectly implied previously. Those 
additional factors which increase LES tone are decrease in intragastric hydrogen 
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ion concentration, bethanechol, and me toe 1opramide. Those additional factors 
which decrease LES tone are increase in intragastric hydrogen ion concentra¬ 
tion, anti-cholinergics, ganglion blockers, nicotine (smoking), ethyl alcohol 
and chocolate. Surgical procedures which increase LES tone are hiatal hernia 
3 k 
repair and fundoplication . ’ 
Mechanical Factors Preventing Reflux 
Mechanical determinants of LES pressure form another important group in 
3 
retarding the development of reflux esophagitis. Dodds, et al divide these 
mechanical factors into five groups; valve mechanisms, extrinsic compression, 
intra-abdominal esophageal segment, mucosal choke, and the spiral stretch 
mechanism. The valve mechanisms include a mucosal flap, a flutter valve, an 
acute esophagogastric angle, an abdominal sphincter segment, and the gastric 
sling fibers. Extrinsic compression at or near the hiatus is created by the 
diaphragmatic pinchcock, a hepatic tunnel, sling action of the right crus, an 
esophagogastric "joint", and the phrenoesophagea1 membrane. The fact that a 
small portion of the LES lies within the abdominal cavity allows sphincter 
buttressing by surrounding intra-abdominal pressure. The mucosal choke hypo¬ 
thesis proposes that during sphincter closure, adhesive forces which resist 
sphincter opening exist between interdigitating mucosal folds. Lastly, 
Stelzner suggests closure of the terminal esophagus is maintained by a mech- 
3 
anical spiral stretch mechanism. 
It is interesting to note at this point that hiatal hernia disrupts many 
of these mechanical barriers to reflux, and an increase in esophagitis among 
persons with hiatal hernia has been repeatedly noted. Although hiatal hernia 
most likely does predispose to reflux esophagitis, there are many arguments 
which diminish its role. Behar summarizes these as follows: 
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1) The incidence of sliding hiatal hernia in the general population is 30% 
to 50%, yet only 5% claim symptoms of reflux esophagitis. 
2) Endoscopic or radiographic diagnosis of sliding hiatal hernia is often 
inaccurate leading to bias as an explanation for the association. 
3) Some hiatal hernias may result from reflux esophagitis, since function¬ 
al shortening of longitudinal muscle fibers has been induced experimental¬ 
ly with contraction of the esophagus and upward shift of the stomach. 
A) Reflux symptoms correlate better with sphincter incompetence than with 
the presence or absence of hiatal hernia. 
5) Although surgical repair of sliding hiatal hernia leads to symptomatic 
improvement, it also increases sphincter pressures that could be related 
to change in 1ength-tension character i stics of the LES circular smooth 
6 
muse 1 e. 
Nature of Refluxed Material 
The next group of factors important as determinants of reflux esophagitis 
concern the nature of the refluxed material and the volume of material avail¬ 
able for reflux. Probably the most important substances causing esophagitis 
are acid and pepsin. Goldberg, et al studies the role of both of these in 
causing acute esophagitis in the cat. They found that hydrochloric acid alone 
at pH 1.0 and 1.3 caused esophagitis, while esophagitis did not occur at a pH 
greater than 1.3 (with one exception). Pepsin, when added to hydrochloric acid 
at pH 1.0 did not increase the severity of the esophagitis. At pH 1.3, however, 
the addition of pepsin did increase the severity of esophagitis and at pH's of 
1.6 and 2.0, the addition of pepsin created esophatitis. At pH 2.3, the combin- 
ation of pepsin and hydrochloric acid did not create esophagitis. An explana¬ 
tion of these findings is found when one considers that esophagitis may be caused 
by different mechanisms. At a pH of 2.0 or less, hydrochloric acid causes esophag¬ 
itis by denaturation of proteins. Pepsin, on the other hand, becomes maximally 
12 
active at a pH of 2.0 and causes esophagitis by protein digestion. 

- 8 - 
In regard to the nature of the material refluxed, substances other 
than acid and pepsin must be considered in the production of esophagitis. 
Esophagitis is found frequently among the elderly, many of whom have dimin¬ 
ished gastric acid secret ion,and has also been found in patients with achlor¬ 
hydria. Bile has a corrosive effect on the esophageal mucosa and appears to 
increase the permiability of the esophageal mucosa to hydrogen ion. High con¬ 
centrations of bile have been found in postprandial samples of gastric con¬ 
tents in patients with reflux esophagitis. Pancreatic enzymes may also have 
3 
a role in the production of reflux esophagitis. 
Volume of Refluxed Material 
Another factor in determining reflux is the volume of the stomach con¬ 
tents and volume of the stomach itself. Increased intragastric pressures 
would naturally result sooner in patients with subtotal gastrectomies than in 
patients with normal gastric anatomy if both were given continuous oral feed¬ 
ings. The volume of gastric contents is determined by rate of input versus 
rate of emptying. The rate of input is a function of eating habitus as well 
as the gastric secretory rate. The gastric emptying rate is multifactorial. 
Factors which increase the gastric volume and thus the amount of material 
available for reflux include obstruction either at the level of the stomach 
or distally; abnormally slow gastric motility secondary to neural, humoral, 
inflammatory, or anatomical factors; vagotomy; drugs; and various diseases 
such as diabetic neuropathy leading to damage to vagal trunk nerve fibers.^ 
Esophageal Clearance 
The rate at which the esophagus clears the refluxed material is important 
in the production of esophagitis. Many studies have shown that an increase in 
esophageal mucosal exposure to gastric contents leads to an increase in the rate 
of development and severity of esophagitis. The esophagus is cleared by pri¬ 
mary and secondary peristalsis. Primary peristalsis occurs with swallowing, 
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creating a contractile wave in the esophagus which propagates distally from 
the mouth, encouraging esophageal clearing. Various states which discourage 
swallowing may thus be important in the production of esophagitis. Various 
theories regarding the development of reflux esophagitis contend that esopha¬ 
gitis probably develops while sleeping when the incidence of swallowing de¬ 
creases and the horizontal position of the body (especially if supine) creates 
gravitational assistance in the production of reflux. The rate of swallowing 
is also influenced by sa1ivat ion wh ich increases swallowing and thus esophageal 
clearing, but also increases the volume of gastric material available for reflux 
Alteration of esophageal motility following a swallow has also been im¬ 
plicated in the production of esophagitis. Studies show abnormal esophageal 
motility in at least 20% of patients with reflux symptoms, although the cause- 
effect relationship has not been ascertained. The predominant motor abnormal¬ 
ity following deglutition appears to be an increased incidence of non-perIsta1t 
and low amptitude contractions, often repetitive, in the distal esophagus which 
3 
cause ineffective esophageal emptying when the subject is recumbent. 
Secondary peristalsis is induced by esophageal distention such as that 
created by gastric reflux, resulting in emptying of esophageal content. Dis¬ 
eases such as scleroderma, diffuse esophageal spasm, and severe esophagitis, 
which decrease the propulsive force or cause motor incoordination, interfere 
with esophageal clearance, prolonging the duration of contact of refluxed 
6 
material with esophageal mucosa, and increase the severity of esophagitis. 
A similar mechanism may be present in patients with acute post-operative 
3 
esophagitis in whom esophageal motor function was depressed during anesthesia. 
Mucosal Resistance 
Various factors determine the ability of the esophageal mucosa to resist 
inflammation by gastric contents. Studies have shown that the stratified 
squamous epithelium lining the esophagus is more sensitive to the digestive 

10 
action of gastric juices than any other mucosa in the gastrointestinal tract. 
Also, the esophagus secretes very little material which can serve as a buffer 
for refluxed gastric acid. The factors which appear to play a role in decreas 
ing the resistance of esophageal mucosa to refluxed material are as follows: 
1) Negative nitrogen balance, suggested by animal studies. 
2) Mucosal changes accompanying aging. 
3) Alterations in esophageal vascular perfusion, either due to decreased 
cardiac output or vascular disease. 
A) Increased frequency of insult. 
5) The many factors involved in the rate and quality of the healing of 
3 
esophageal mucosa. 
Another factor which is gaining importance with regards to mucosal re¬ 
sistance is "cytoprotection". Studies in animals indicate that the degree of 
inflammation created by gastroesophageal reflux may be mediated through prosta 
glandin formation. Various theories have been proposed. Studies by Brown, 
et al have suggested that inhibition of prostaglandin synthesis with i ndo- 
methacin protects the esophagus against development of experimental esopha¬ 
gitis in the cat. In addition, indomethacin prevented the diminished con¬ 
tractility of the LES and the diminished response of the LES to exogenous 
edrophonium.^ Similar studies on animal gastric mucosa suggest other 
hypotheses. Robert, et al studied the prevention of gastric necrosis in rats 
and came to the following conclusions: 
1) Various prostaglandins as well as mild irritants (20% ethanol, 0.35N 
hydrochloric acid, 0.075N sodium hydroxide, A% sodium chloride, water 
at 70°C) are cytoprotective against several necrotizing agents (ab¬ 
solute ethanol, .6N hydrochloric acid, .2N sodium hydroxide, 25% 
sodium chloride, boiling water) in the stomach. 

2) Indomethacin blocks the protection afforded by mild irritants, but 
not by prostaglandin. 
3) They propose that mild irritants protect the gastric mucosa by inducing 
the endogenous formation of cytoprotective prostaglandin by the stomach. 
4) Formation of cytoprotective prostaglandin may be a physiologic phenomenon 
that maintains the integrity of gastric mucosa cells in spite of the 
1 b 
"hostile" nature of the gastric contents. 
Robert, et al even suggest that cytoprotective prostaglandins may be 
beneficial in the treatment of reflux esophagitis.^ It is clear that more 
work need be done to define the importance of "cytoprotection" and the role 
of prostag 1 andins . 
Feline LES Smooth Muscle Studies in Esophagitis 
The cat, opossum, rat, guinea pig, rabbit, and other animals have been 
used successfully as experimental models in studies involving the LES and 
esophagitis. Much of the current work has been done by Castel1, et al whose 
work with feline esophagitis is in part summarized below. 
Studies utilizing cats have shown that esophageal inflammation produces 
LES hypotension.^ Castel1, et al developed a model whereby cats received 
a 30 minute perfusion of 0.1N HC1, 5 cm above the LES on four consecutive 
days. This produced biopsy-documented esophagitis and marked decrease in LES 
pressure which was accompanied by a decreased responsiveness to pentagastrin and 
also an impaired response to edrophonium. As the cholinesterase inhibitor, 
edrophonium, requires an intact cholinergic effector unit for its action, 
these observations indicate that pentagastrin acts at the level of the 
postganglionic nerve of the cholinergic system. Inflammation may impair the 
functional integrity of a cholinergic pathway regulating LES tone. LES response 
to bethanechol, whose action is directly at the neuromuscular junction,^ was 
impaired by inflammation. This suggested that LES smooth muscle is unaffected, 
acutely at least, by inflammation. Morphological studies of the full section 

12 
biopsies showed further evidence that the smooth muscle was unaffected by 
inflammation. Electron microscopyindicated that although neutrophils were 
observed between muscle bundles in the HCl-perfused cats, the muscle fibers 
20 
themselves were normal. 
It has been previously noted that patients with symptoms of reflux 
esophagitis have lower resting LES pressures than normal subjects.^ 
Patients with reflux esophagitis have also been shown to have an impaired 
212? ... 
response to edrophonium and pentagastrin , ’ as well as a diminished 
21 23 
response to bethanechol. ’ Castell, et al explain this disparity between 
the feline model of esophagitisand patients with reflux esophagitis by pointing 
out that the feline model deals with acute inflammation, while patients with 
reflux esophagitis represent a chronic model. They suggest that the chronicity 
of the esophageal inflammation in reflux patients may have produced smooth 
muscle dysfunction, so as to impair the LES response to bethanechol. It is 
further concluded that it seems reasonable to question whether LES smooth 
muscle dysfunction plays a role in the pathogenesisof gastroesophageal reflux, 
20 
or is simply a result of chronic inflammation. 
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MATERIALS AND METHODS 
The present study is comprised of two major components, an in vivo section, 
and an in vitro section. As much of the methodology is the same, and as many 
of the cats were used in both studies, they will be described concurrently 
when possible. 
51 adult cats of either sex were selected. They weighed between 3 and 5 kg 
Each was anesthetized with ketamine (0.2 cc/kg initially and 0.1 cc/kg q 30-^5 
min. P.R.N.) and had a bite block in position. The in vivo LES was identified 
with a pressure measuring probe 1.8 mm in outside diameter, having a perfused 
side opening adjacent to a metal plug obstructing the distal tip. Location of 
the LES with this one-hole probe was confirmed by at least three pull-through 
measurements, identifying gastric, LES, and esophageal body pressures with each 
pull-through. The distance from the LES to the incisors was noted. A "Dent 
sleeve"^ probe was then positioned with the distal opening registering 
gastric pressure, the sleeve portion registering LES pressure, and the proximal 
opening registering esophageal pressure. Distance from incisor to LES was 
confirmed as were pressure readings from each area with respect to the one- 
hole measurements. Further verification of LES location was gained from physio 
logic correlation with pressure tracings by noting the following: 1) Swallowing 
initially exhibited a rapid very high pressure reading in the esophagus with 
a simultaneous decrease in pressure or relaxation of the LES. Soon thereafter, 
the LES pressure would increase rapidly and maintain a sustained after-contrac- 
tion (Figure 1); 2) the respiratory pattern registered by the esophageal and 
gastric openings were opposed, being situated on opposite sides of the diaphragm 
(Figure 2). Having located the LES, with the "Dent sleeve" in place, the 
catheter was taped to the bite block and the cat allowed to rest until a stable 
baseline LES pressure was recorded. 
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Suction biopsies were obtained at 1, 2, 4, and 5 cm proximal to the LES. 
Samples from the 1 and 5 cm sites were placed in formalin to be reviewed histo¬ 
logically for changes during the course of the experimental period. Samples 
from the 2 and 4 cm sites were incubated at 37°C for 6 hours with ^H-thymidine 
in organ culture. From these latter samples, autoradiographs were prepared, 
coded, and interpreted blindly by a colleague. For each, 1000 consecutive epi- 
3 
thelial cells in the bottom 2 layers of squamous mucosa were examined and H- 
thymidine labeled cells were counted to determine esophageal mucosal thymidine 
uptake in response to acute experimental esophagitis. The cats were fasted 
the night prior to each biopsy, but otherwise allowed to eat normally. 
This procedure occurred 3 times during each cat's experimental period: 
once prior to any acid or drug infusion, once one day following the 4 day acid 
infusion, and once 21 days following the last day of acid infusion, i.e. day 
23 of the experimental period. (This final measurement does not apply to the 
in vitro cats.) The cats were divided into the following groups. 
Acid Control Group 
After the initial study on day 1 described above, 17 cats (12 for the in 
vitro series and 5 in vivo) were administered 0.1N HC1 via a polyethylene tube 
whose distal end was situated 7 cm proximal to the LES. The cat's head and 
upper body were supported on a foam rubber wedge to promote drainage of the 
HC1 into the stomach. HC1 was infused using a Harvard pump at 0.92 cc/min for 
30 min on 4 consecutive days. On the 5th and 25th days, LES pressures were 
recorded and biopsies performed as noted above. 
High Dose I ndocin (4 mg/kg) Group 
15 cats (6 for the in vitro series and 9 in vivo) were treated identical¬ 
ly to the acid control group with the exception that they were administered 
Indocin, 2 mg/kg IV bolus, immediately prior to each HC1 infusion and another 
2 mg/kg immediately after each HC1 infusion. 

Low Dose Indocin (150 yg/kg) Group (In Vivo Series Only) 
5 cats were treated as above, but with Indocin 75 bg/kg IV bolus immedi¬ 
ately prior to each HC1 infusion and another 75 yg/kg immediately after each 
HC1 infusion. 
Metoc1opramide (10 mq/kg) Group (in Vivo Series Only) 
5 cats were treated as acid control group, but given metoc1opramide, 5 
mg/kg IV bolus, immediately prior to, and after each HC1 infusion. 
Prostaglandin E2 (1 yg/kg/min) Group 
5 cats (cats served for both in vivo and in vitro studies) were treated 
as acid control group, but received prostaglandin E2 at 1 yg/kg/min for 20 min 
or 18.4 cc at 0.92 cc/min IV infusion via the Harvard pump. The 20 min infu¬ 
sion was completed immediately prior to HC1 infusion. 
Prostaglandin F2« (5 yg/kg/min) Group 
4 cats (cats served for both in vivo and in vitro studies) were treated 
as above, but with prostaglandin F2a at 5 yg/kg/min x 20 min or 18.4 cc at 
0.92 cc/min immediately prior to HC1 infusion. Note that neither prostaglan¬ 
din group was biopsied prior to acid infusion, nor were LES pressure measure¬ 
ments made and biopsies achieved on day 25 for these 2 groups. Both did have 
LES pressures measured prior to and after 4 days of HC1 infusion and biopsies 
were performed on day 5. 
Non-acid Control Group 
9 cats received no treatment and served as controls for the in vitro 
series as described below. 
In Vitro Studies 
36 cats, including 9 non-acid control cats, 12 acid control cats, 6 high 
dose indocin cats, 5 prostaglandin E2 cats, and 4 prostaglandin F2a cats were 
utilized for in vitro studies, after having completed days 1-5 of in vivo 
studies as described above (the 9 non-acid control cats had no treatment). 
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On day 5, the cats were anesthetized with ketamine (0.3cc/kg) and the esopha¬ 
gogastric junction was exposed. The in vivo LES was again identified with the 
one-hole probe. With the catheter side opening located at the point of high¬ 
est pressure, a pin was placed on the outer surface of the LES. The position 
of the pin was adjusted under fluoroscopy to coincide with the proximal end 
of the metal plug on the probe. In this manner, the precise location of the 
side opening was identified on the LES outer surface, and a suture was used 
to mark the location of the LES high pressure point (Figure 3). Figure 4 
shows the esophagus and stomach of a cat in which the LES high pressure point, 
as well as the upper and lower limits of the ring dissection have been identified. 
The stomach, LES, and a 5 cm esophageal segment were removed together and 
stretched to the previously measured in vivo length. Twenty consecutive trans¬ 
verse rings were cut with razor blades neld in a metal block 1.75 mm apart. 
Twelve adjacent rings were selected from the region of the gastroesophageal 
junction; the ring identified by the suture, two rings distal, and nine rings 
proximal. The twelve rings were mounted in a multiple chamber muscle bath as 
shown in Figure 5. Each ring was suspended between two platinum wire hooks 
0.25 mm in diameter. The lower hook was rigidly attached to the bottom of the 
muscle bath. The upper hook was attached to a force transducer (UC2 cell 
Statham Instruments) which was mounted on a micrometer stage (Edmund Scientific 
Co.). The micrometer monitored deformation to within 0.1 mm accuracy. The 
stretch applied to the rings was measured by the distance between the hooks. 
After mounting, the rings were allowed to equilibrate for 30 minutes with the 
distance between the hooks at 12 mm. 
Temperature was maintained in the chamber at 37°C by warming the perfusate 
through a glass coil heat exchanger, heated by water from a constant tempera¬ 
ture circulating pump (Haake, model FE), and by regulating the temperature in 
the water jacket surrounding the muscle chamber. Chamber temperature was moni¬ 
tored with a telethermometer and thermistor probe (Yellow Springs Instrument 
Co-;,, Inc.). 

The bath was perfused continuously with tyrode solution. The tyrode solu¬ 
tion contained (in mM/liter): NaCl, 137; NaHCO^, 12; NaH^PO^, 1.8; KC1, 2.7; CaCl^, 
2.7; Glucose, 5.5; and MgCl^, 1.0. The perfusate was equilibrated with a gas 
mixture containing 95% 0^ and 5% CO^ with a pH of 7-2. 
After the initial 30 minute equilibration period in tyrode solution, the 
force developed by each of the rings was recorded (basal force). The solution 
was then replaced by a tyrode solution to which 1 AO mM KC1 had been added. 
This solution depolarized the muscle causing a sustained contraction (total 
force). After 15 minutes, the KC1 solution was replaced for 10 minutes by a 
calcium-free tyrode solution containing 5 rnM ethyl ened i ami ne tetraacetate disodium 
salt (EDTA). This solution binds extracellular free calcium causing the muscle 
to relax completely (passive force). (Figure 6). The force developed by 
contraction of the muscle (active force) is the difference between total and 
passive forces. After the muscle was fully relaxed, it was stretched to a new 
length, and the sequence was repeated. The ring specimens were each tested 
at 12, 2A, 28, 30, 32, 3A, 36, 38, and A0 mm distance between the hooks or at 
least 2 stretches beyond their peak maximal active force generation. 
Histological Correlation 
After the last stretch and readings, the rings were then placed in indivi¬ 
dually labeled vials of formalin to be examined histologically for mucosal and 
muscle damage and for location of the squamoco1umnar junction. Both the ring 
biopsies and the hand suction biopsies were histologically graded in the follow¬ 
ing manner: 
Mucosal Grading 
Grade 0: Normal mucosa 
Grade 1: Rash (reflux associated squamous hyperplasia) 
Grade 2: Esophagitis (as defined earlier) plus inflammation 
Grade 3: Esophagitis, inflammation, and mucosal ulceration 
/ 
Grade k: Complete absence of, or obliteration of, the definition of the 
mucosa with granulation tissue 
Muscularis Propria Grading 
Grade 0: Normal smooth muscle 
Grade 1: Invasion by granulation tissue and/or inflammatory tissue with 
no direct evidence of necrosis or specific muscle fiber involve¬ 
ment 
Grade 2: Specific evidence of muscle cell degeneration and necrosis 
Dose Response Studies 
Each drug used in the previous studies was tested for its pharmacologic 
effect and to determine effective dosages. Figures 7 and 8 show the change in 
LES pressure from baseline during administration of the following drugs at the 
various dosages indicated; Indocin (IV bolus), Metoclopramide (IV bolus), 
Prostaglandin E2 (IV bolus and 20 min IV infusion), and Prostaglandin F2a 
(IV bolus and 20 min IV infusion). Pressures were monitored as previously 
explained using the "Dent sleeve." The degree of response was measured as 
the difference between the pressure peak (either positive or negative) developed 
after drug administration and the resting LES pressure. 

- 19 - 
RESULTS 
Dose Response Studies 
As is shown by Figures 7 and 8, prostaglandin E2, prostaglandin F2a, and 
metoc1 op ramide increased LES pressure while indocin decreased LES pressure at 
the dosages tested. While each cat tested absolutely exhibited the above 
findings, there was significant variability with regards to the degree of 
response. As the purpose of these dose response tests was to determine 
effective dosages, the dosages chosen for use in the in vivo and in vitro 
studies all showed the desired effect in all cats tested. In general, as shown 
by Figures 7 and 8, increased dosages created increased LES response. 
In Vivo Studies 
Figure 9 gives the resting LES pressures for the various groups studied 
on the days tested. Figure 10 displays these results graphically. All groups 
show a significant (p < .05) decrease in resting LES pressure after induction 
of esophagitis and a return by day 25 of a resting LES pressure similar to that 
in the basal state. Neither indocin (A mg/kg), indocin (150 yg/kg), metoc1opramide 
(10 mg/kg), prostaglandin E2 (1 yg/kg/min x 20 min), nor prostaglandin F2a 
(5 yg/kg/min x 20 min) had any significant effect in preventing the decrease 
in resting LES pressure secondary to experimentally induced esophagitis in vivo. 
Histology study showed that the esophageal mucosa was similar on days 1 and 
25 indicating the transient nature of the esophageal inflammation which was 
present on day 5- 
In Vitro Studies 
As previously described, the in vitro studies consist of contrasting the 
normal feline distal esophageal force-length characteristics (non-acid control 
group) with the force-length characteristics of the non-treated acid control 
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group, the high dose indocin group, the prostaglandin E2 group, and the 
prostaglandin F2ct group. 
Non-Acid Control Group. Figures 11 through 16 show force-length relation¬ 
ships for a ring corresponding to the high pressure point (LES) as identified 
by a suture placed under fluoroscopy and for alternative rings taken from the 
esophageal side, i.e., 2, k, 6 and 8 proximal, and from the gastric side, 
i.e., 2 distal. As has been explained, the total force curve was obtained during 
full muscle contraction in tyrode with KC1, and the passive force curve during 
relaxation in EDTA. The active force is given by the difference between 
total and passive forces and represents the force developed by muscle contrac¬ 
tion. The basal force is obtained in tyrode solution and the difference be¬ 
tween basal and passive force, the basal-active force, represents the level of 
activation of the muscle while in tyrode solution. Unlike other muscular 
structures which exhibit no contractile activity while in physiologic solu¬ 
tion, muscle from the distal esophagus maintains a state of tonic contracture, 
which is at least halfway between fully contracted and fully relaxed. In 
particular, the ring from the high pressure point, which in Figure 12 is desig¬ 
nated LES, develops approximately 80% of its full contractile force in tyrode 
solution. It should be noted, however, that the LES ring is not the only 
specimen originating from the high pressure zone. Two rings distal and two 
rings proximal to the LES ring are included in, and form the borders of, the 
in vivo high pressure zone. As is also shown here, the peak maximal active 
force is not developed while at the in vivo length, but while stretched to 2 
to 4 times the in vivo length. 
The same data is presented differently in Figures 17 through 21, where 
the basal, total, passive, active and basal-active curves of the rings tested 
are compared to one another. The Figures show that the ring corresponding to 
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the in vivo high pressure point exhibits the highest basal, total, active, 
and basal-active curves of all rings tested. The LES passive curve is not 
significantly different from the rest of the esophageal rings. 
Figure 22 shows the maximum active force developed by the LES and esopha¬ 
geal rings in succession. Figure 23 shows the length at which maximum active 
force (MAF) is developed. The MAF shown in Figure 22 was obtained by averag¬ 
ing the MAF developed by individual rings, regardless of the length at which 
it occurred. Since all rings did not peak at the same stretched length, 
averaging active forces at specific lengths, as shown in Figures 11 through 21, 
yields slightly lower peaks in the active force curves. The MAF developed 
by the ring corresponding to the in vivo high pressure point is significantly 
higher than that of adjacent rings. The stretch length of MAF development 
decreases gradually from the LES region toward the esophagus. 
Comparison In Vitro Studies. Figures 2A through 29 display the post¬ 
acid companion studies to Figures 11 through 16. These are the force-length 
relationships for alternate rings 2 distal through 8 proximal taken on day 5 of 
the experimental period, i.e., after experimental induction of esophagitis. 
Total, basal, active, passive, and basal-active forces are derived as has been 
previously described. 
The differences in the pre and post-esophagitis studies can be more easily 
appreciated in Figures 30 through 33- Figure 30 compares the basal forces of 
adjacent rings in the non-acid control group (labeled control) to those of 
the acid control group (labeled esophagitis). The ring corresponding to 
the in vivo high pressure point (HP) is represented by the thick continuous 
line. In tyrode solution, the basal force of the high pressure point of the 
non-acid control group is higher than all other adjacent rings. This is in 
agreement with the findings of Christensen and co-workers.^ In the acid 
control group, the basal forces of all rings are reduced with respect to the 
non-acid group. The basal forces of the ring representing the high pressure 
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point, however, are more profoundly reduced after esophagitis than adjacent 
rings, such that its forces cannot be distinguished from those basal forces 
of the other rings, a finding not present in the non-acid control group. 
Figure 31 compares the passive forces of adjacent rings in the non-acid 
control group (labeled control) with those of the acid control group (labeled 
esophagitis). The passive force curves are similar for both groups. It should 
be noted that the passive force curve of the high pressure point (solid 
black line) is not different from those of adjacent rings in either group. 
Figure 32 shows the difference between the basal and passive forces (basal- 
active forces) for the non-acid control group (labeled control) and the acid 
control group (labeled esophagitis). As expected, the high pressure point 
ring of the non-acid control group (solid line) has the highest basal-active 
forces of all rings tested. After the onset of esophagitis, however, the 
basal-active forces of all rings, especially those of the high pressure point, 
are essentially eliminated. This finding corresponds directly with the in 
vivo finding that the LES was not able to develop tonus in basal conditions. 
Figure 33 compares the active forces of adjacent rings in the non-acid 
control group (labeled control) with those of the acid control group (labeled 
esophagitis). As described, the active force is the difference between the 
total force, as developed in tyrode with KC1, and the passive force, as de¬ 
veloped in tyrode with EDTA. The active force represents the maximum con¬ 
tractile force developed under conditions of maximum stimulation. As shown 
in the non-acid control group, the ring corresponding to the in vivo high 
pressure point (solid line) exhibits the highest active forces. In the acid 
control group, all active forces are reduced, with the active forces of the HP 
ring being reduced even more prominently than those active forces of adjacent 
rings, such that it can no longer be distinguished from the others. Also 
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evident in this Figure is that the maximum active force is developed at ap¬ 
proximately 30 mm distance between hooks for both non-acid and acid control 
groups. 
The maximum active forces developed by each individual animal in the non¬ 
acid (control) and acid (esophagitis) control groups are compared in Figure 3*+- 
For each group, maximum active forces from the high pressure point (HP) repre¬ 
sent the LES while the maximum active forces from the esophagus are represented 
by the fourth ring proximal to the high pressure ring (AP) . The mean maximum 
active force of the LES of normal cats is 12.22 grams. After experimental in¬ 
duction of esophagitis, the mean maximum active force of the LES is reduced to 
7.85 grams, a significant reduction (p < 0.01). The rest of the esophagus, 
however, generates virtually the same mean maximal active force both prior to 
and after esophagitis. The normal mean maximum active force at the fourth prox¬ 
imal ring was 9-86 grams while the mean for the esophagitis group was 8.AA grams. 
Thus, esophagitis reduces the maximum active force developed by the LES, but not 
the maximum active force developed by the rest of the esophagus under conditions 
of maximum in vitro stimulation. The maximum active force developed by the LES 
after esophagitis is comparable to the maximum active force developed by the 
rest of the esophagus before and after esophagitis. 
In Vitro Histologic Correlation. In order to explain the magnitude of the 
range of LES maximum active forces found in the cats with esophagitis, this group 
was divided into those with maximum active forces greater than the mean of 7-85 
grams and those with maximum active forces less than 7-85 grams. As has been 
previously explained, each distal esophageal ring studied in vitro was thereafter 
examined under the light microscope by a pathologist and numerically graded with 
respect to degree of histologic mucosal damage. Note was also made of the 
histological status of the muscularis propria. As previously stated, 
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the grading scale ranged from no mucosal damage or "0" to complete absence 
of or obliteration of the definition of the mucosa with granulation tissue 
or "A". Blind gradings of the LES rings of the 7 cats who were able to 
develop maximum active forces greater than 7-85 grams showed a mean of 1.83 
on the 0-4 mucosal histologic scale. Blind gradings of the LES rings of the 
5 cats who developed maximum active forces less than 7-85 grams showed a mean 
of 3.50 on the 0-4 mucosal scale. This indicates that those cats who could 
develop the higher maximum active forces (greater than 7-83 grams) had less 
histologic mucosal damage than those cats who could not develop high maximum 
active forces (less than 7.85 grams) under conditions of maximum in vitro 
stimulation. A constant observation of mild muscle edema and vacuolization 
was present in the muscularis propria of most cats, whether controls or pre¬ 
treated. These findings were regarded by the pathologist as secondary to 
tissue manipulation and stretching. 
Figures 35 through 39 compare the various 1ength-tens ion characteristics 
previously defined with respect to the LES rings of the non-acid control 
group (labeled control), the acid control group (labeled esophagitis), those 
cats in the acid control group with above average maximum active forces (la¬ 
beled MAF >7-85), and those cats in the acid control group with below average 
maximum active forces (labeled MAF <7.85). The crosses on each figure repre¬ 
sent values significantly different than those of the non-acid control group. 
The passive forces of the LES rings achieved by each group at the vari¬ 
ous stretch lengths indicated, i.e. 12, 24, 28, 30, 32, and 34 mm, are dis¬ 
played graphically in Figure 35. As described, the passive force is that 
generated by each LES ring while in tyrode solution with EDTA. As is visual¬ 
ized, there is no significant difference in the amount of passive force gen¬ 
erated in any of the acid control groups at any of the stretch lengths tested 
when compared to the non-acid control group. Thus, before and after esophagi¬ 
tis, passive forces at the level of the in vitro LES remain unchanged. 
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The basal forces of the LES rings of each group at the various stretch 
lengths are displayed in Figure 36. The basal force is that generated by the 
LES ring while in tyrode solution. As is shown, the capacity to produce a 
basal force has been significantly reduced in all of the acid control groups 
at almost all stretch lengths tested with respect to the non-acid control 
group. These basal forces after esophagitis are comparable to the passive 
forces displayed in Figure 35. Thus, after induction of esophagitis, the in 
vitro LES lost the capacity to maintain a basal tonus in physiologic solution. 
Figure 37 displays the total forces of the LES rings of each group at the 
various stretch lengths. The total force is the force of contraction generated 
under conditions of maximum stimulation with tyrode and KC1. Here, both the 
acid control group arid those cats of the acid control group with MAF < 7-85 
show a significant decrease in the total contractile capacity with respect to 
the non-acid control group. Those animals of the acid control group with less 
histologic damage and MAF > 7-85 had essentially the same total force production 
as normal cats. Thus, after induction of esophagitis, the in vitro LES shows 
a diminished capacity to contract when stimulated maximally. The magnitude 
of the loss of contractility appears to be directly related to the degree of 
histological damage. 
Figure 38 displays the active forces generated at the LES by each group at 
the various stretch lengths. The active force is equal to the total force 
less the passive force. Because the passive forces at the LES were essentially 
equivalent in the acid and non-acid control groups, the changes noted in the 
total forces are again noted in the active forces. Again, both the acid control 
group and those of this group with MAF < 7-85 show a significant decrease in 
active force at the LES with respect to the normal cats. Those cats with slight 
histological damage showed essentially the same LES active force production as 
normal cats while those with severe mucosal damage showed a significant de¬ 
crease in in vitro LES contractility. 
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The basal-active force is equal to the basal force less the passive force. 
Figure 39 displays graphically the LES basal-active forces at the various 
stretch lengths. Again, due to the fact that esophagitis did not affect the 
passive contractile forces of the in vitro LES, the basal-active force results 
reflect those of the basal forces in that all the cats of the acid control 
group showed a significant decrease in basal-active forces. This loss of 
capacity to produce basal forces in vitro is independent of the degree of 
histological damage. 
Figures AO through AA are analagous to Figures 35 through 39 except that 
the various length tension characteristics of the esophagus, represented by 
the fourth ring proximal to the high pressure ring, are now being displayed. 
Again, the non-acid control group is compared with the acid control group as 
a whole and with those cats of the acid control group with MAF > 7-85 and 
those with MAF < 7.85. As before, the crosses on the graphs represent values 
that vary significantly from the non-acid control group. 
Figure AO shows the passive forces of the AP rings of each group at the 
various stretch lengths. Here, as at the LES, there is no significant dif¬ 
ference in the passive forces between the non-acid control groups and any of 
the acid control cats. Thus, both at the LES and distal esophagus, in vitro 
passive forces are the same with or without esophagitis. 
The basal forces of the AP rings of each group are shown in Figure Al. 
As with the passive forces, there is no significant difference in the basal 
forces generated when comparing the non-acid control group with any of the 
acid control groups. When compared with Figure 36, the differing behavior 
of the LES with the rest of the esophagus is apparent. After induction of 
esophagitis, the in vitro LES loses the capacity to maintain a basal force 
while the rest of the in vitro distal esophagus maintains the same basal force 
before and after esophagitis. This fact was found to be true even in those 
cats with relatively little histologic damage. 
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Figure b2 displays the total forces produced at the various stretch 
lengths by each group at the bP level. There is no significant difference 
between the total force generated by the non-acid control group and that gen¬ 
erated by the acid control group as a whole. Those cats with the more 
severe histological damage, however, did show a significant reduction in the 
total force generated at the bP ring with respect to the non-acid control cats. 
The generation of total force was more significantly reduced at the LES than 
at the AP ring after induction of esophagitis (Figure 37). The reduction 
in total force generated in vitro after induction of esophagitis is directly 
dependent on the degree of histologic damage at the LES and other esophageal 
1 eve 1s . 
The active forces of the AP rings of each group are shown in Figure A3. 
As with the total forces, there is no significant difference between the active 
force of the non-ac i d cont ro 1 group and that of the acid control group as a whole. 
The cats with more severe histologic damage showed a significant decrease in 
active force production at the AP ring. Comparing this figure with Figure 38 
shows that esophagitis more significantly reduced the in vitro production of 
active force at the LES than at other distal esophageal levels. The esopha¬ 
gitis-induced reduction in active force production at both the LES and AP 
rings is directly dependent on the severity of the histologic damage. 
The basal-active forces generated by the AP rings are shown in Figure bb. 
There is a significant reduction in basal-active forces produced by the acid 
control group when compared to the non-acid control group at the bP ring. 
Those cats of the acid control group with little relative mucosal damage showed 
no significant difference in basal-active forces when compared with the non¬ 
acid control group. As shown in Figure 39, after esophagitis, all acid 
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control cats showed significantly reduced basal-active forces at the LES. 
At the 4P level, the reduction in basal-active forces was directly related to 
the degree of histologic damage, while at the LES, the reduction was independent 
of the degree of damage in this study. 
In Vitro Indomethacin Studies. As explained in the Materials and Methods 
Section, 6 cats were treated identically to the acid control group except 
that they received indocin 2 mg/kg IV bolus immediately prior to and 
another 2 mg/kg IV bolus immediately after each HC1 infusion. Figure 45 dis¬ 
plays the passive, basal, total, active, and basal-active forces produced by 
the LES at the various stretch lengths tested. These results can be compared 
with the results on Figures 30 through 33 to determine the influence of indo¬ 
methacin at 4 mg/kg during the experimental induction of esophagitis. The 
comparison shows that the 6 cats given indocin displayed no significant 
difference in the production of passive, basal, total, active, and basal-active 
forces when compared to the acid control group. This holds true both at the 
LES and other distal esophageal rings (through 8 rings proximal to the LES). 
Figure 46 illustrates another presentation of the comparison of the indocin and 
acid control groups. Thus, in this study, indomethacin administered as described, 
did not influence the changes noted in in vitro basal and active forces in the 
acid control group when compared with the non-acid controls. Furthermore, there 
was no significant histologic difference between the esophageal mucosa of the 
cats receiving HC1 and indocin when compared with the acid control group. 
In Vitro Prostaglandin E2 and F2g Studies. Five cats were treated 
identically to the acid control group except that they received prostaglandin 
E2 at 1 yg/kg/min for the 20 min immediately prior to acid infusion. Four 
cats were treated identically to the acid control group except that they received 
prostaglandin F2a at 5 yg/kg/min for the 20 min immediately prior to acid infusion. 
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The forces generated by each at the various stretch lengths are shown in Figures 
47 and A8 respectively. Both studies suffer from small sample size. There are 
no significant differences when comparing any of the defined forces generated 
by the prostaglandin E2 or F2a group with those of the acid control group or 
non-acid control group. A notable trend, however, which can be seen by compar¬ 
ing Figure A7 with Figure 33, is that the in vitro active force developed at 
the LES by the prostaglandin E2 group approaches the LES active force of the 
non-acid control group, while the LES active force of the acid control group 
is comparatively lower. Furthermore, the prostaglandin E2 group showed some 
tendency to less histologic damage than the acid control group. There was no 
histologic difference between the prostaglandin F2a group and the acid control 
group. 
3 
H-Thymidine Uptake Studies 
As explained in the Materials and Methods Section, hand suction esophageal 
mucosal biopsies were performed 2 and A cm proximal to the LES prior to acid in¬ 
fusion, 1 day after completion of acid infusion, and after the 3 week recovery 
3 
period, i.e., days 1, 5, and 25. These were incubated with H-thymidine in or¬ 
gan culture. Autoradiographs were prepared, the bottom 2 layers of squamous 
mucosa were examined, and labeled cells were counted by a colleague. The label¬ 
ing index (L.I.), defined as the percentage of labeled cells in those 1000 con¬ 
secutive epithelial cells examined for each biopsy, was determined for each 
specimen. Figure A9 shows that mean L.l. ± SEM for both groups (2 and A cm 
proximal to the LES) on experimental days 1, 5, and 25. At 2 cm proximal to 
the LES, the mean L.l. was 1A.3 ± 1.1 on day 1 and 22.2 ± 1.7 on day 5, a signi¬ 
ficant difference (p < .005). On day 25, the mean L.l. was 6.7 ± 1.0, also 
significant (p < .05) when compared with day 1. At A cm proximal to the LES, 
the mean L.l. was 1A.2 ± 1.1 on day 1 which was significantly less (p < .001) 
than the mean L.l. of 30.3 ±2.1 on day 5- On day 25, the mean L.l. at A cm 
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proximal was 10.0 - 1.8, significantly (p < .05) different than on day 1. 
Also, the mean L.l. at A cm proximal to the LES was significantly greater 
(p < .05) than the mean L.l. at 2 cm proximal to the LES on day 5 and on day 
25. These results indicate that esophageal mucosal thymidine uptake increases 
promptly in response to experimentally induced acute esophagitis and returns 
to normal or subnormal values with healing. They also indicate that the site 
of the most severe esophagitis, as defined by thymidine uptake, is the site of 
maximal acid exposure, i.e., the location closest to where the HC1 is being 
in fused. 
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DISCUSSION 
There are many contributing factors to the development of gastroesopha- 
geal reflux. The purpose of this study has been to first define these factors 
as they are known today, and then to further elucidate and expound upon the 
role of esophageal smooth muscle as an important factor. The approach is a 
multidirectional one, involving both in vivo and in vitro analysis, the role 
of various pharmacologic agents, as well as mucosal response to acid injury 
and histologic correlations. 
In Vivo Studies 
Much of what is known about muscle mechanics is derived from data ob¬ 
tained in studies involving striated muscle. The relative scarcity of data 
on mechanical properties of smooth muscle may be in part due to technical 
difficulties encountered while studying it. Unlike striated and cardiac 
muscle, gastrointestinal sphincter smooth muscle relaxes when electrically 
stimulated. Also, many smooth muscles exhibit a spontaneous resting tone 
when placed in physiologic solution. This is particularly true of gastro¬ 
intestinal sphincters. The in vivo LES maintains an area of increased intra¬ 
luminal pressure in its resting state. The increase in pressure is secondary 
to anatomic, pharmacologic, and physiologic factors. After experimental in¬ 
duction of esophagitis with HC1 infusion, the resting intraluminal pressure 
in the LES area is reduced such that it becomes indistinguishable from other 
areasof the esophagus. Three weeks later, however, the resting LES pressure 
returns to normal. These changes occur independent of anatomic factors as 
the anatomy remains unchanged. Histology varies significantly during the ex¬ 
perimental period, however, warranting studies of the rate and location of 
mucosal cellular division. 
Pharmacologic factors were manipulated in an attempt to alter the extent 
of in vivo LES pressure change with esophagitis. Two opposing hypotheses were 
considered with the assumption that the mucosal inflammation resulting from 
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HC1 infusion may be in part mediated by prostaglandin synthesis. The first 
proposed that inhibition of prostaglandin synthesis would protect the esopha¬ 
gus against the development of experimental esophagitis. The second proposed 
that the presence of prostaglandin directly or indirectly resulted in a cyto- 
protective mechanism maintaining the integrity of the mucosal cells. However, 
none of the pharmacologic regimens tested (indocin at A mg/kg, indocin at 150 
yg/kg, prostagl and i n E2 at 1 yg/kg/min for 20 min, prostaglandin F2pt at 
5 yg/kg/min for 20 min, and metoclopramide at 10 mg/kg) had any significant 
effect on the development of LES hypotension with experimental esophagitis. 
Possible explanations inc1ude the use of inappropriate dosages of the before- 
mentioned agents, inappropriate timing of their administration, inappropriate 
route of administration, relatively small sample size, inaccuracy of original 
hypotheses, etc. 
Thus, to summarize the in vivo studies, it can only be said that this 
model produced a transient LES hypotension which correlated with the histo¬ 
logic findings of transiently inflamed mucosa. Mechanical factors producing 
resting LES pressure played no role in hypotension development. Attempts to 
define hormonal control were unsuccessful. The possibility that there is an 
intrinsic difference in LES muscle with respect to other esophageal smooth 
muscle rendering the LES more susceptible to HC1 is specifically dealt with 
in the in vitro studies. 
In Vitro Studies 
In vitro studies of circular muscle strips from various animal species 
show some unique features for the strips taken from the gastroesophageal junc¬ 
tional area. They develop much steeper force-length curves with respect to 
circular muscle from the body of the esophagus, and are more sensitive to the 
effects of several pharmacologic agents. The anatomic location of the high 
pressure point is found 2-3 mm proximal to the squamocolumnar junction. The 
' 
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in vivo high pressure zone extends over an area comprising approximate 1y 5 
rings of 1.75 mm width each, the high pressure point corresponding to the mid¬ 
dle ring. Thus, the rings at the two distal and two proximal locations may be 
assumed to represent areas of transition LES and fundus, and LES and esophagus 
respectively, while the middle 3 rings represent the LES proper. 
Defining the mechanical properties of the LES is complicated by the fact 
that it develops some degree of tonic contraction when placed in tyrode solu¬ 
tion. The LES, thus, has the ability both to relax and to contract in response 
to agents that act on receptors located either directly on the muscle or on 
intrinsic nerves. This characteristic makes it difficult to determine the max¬ 
imum contractile strength of the circular muscles of the LES. First, full 
relaxation, to obtain passive contractile force, was obtained with EDTA in 
tyrode. Full contraction, the active contractile force, could then be deter¬ 
mined with tyrode and KC1. The results of this study indicate that the LES 
develops not only the highest force in tyrode solution, i.e. the highest basal 
force, but also the highest total, active, and basal-active forces, when com¬ 
pared with other rings in the distal esophagus. Its passive force, however, 
is not different from that of other rings. 
Thus, with respect to adjacent muscles, the LES shows increased maximal 
contractile strength as well as increased force in tyrode. This increased 
basal force is entirely due to active tonic contraction, as the passive forces 
of the LES are the same as those of muscles from adjacent locations. The 
small shift present in the passive curves of Figure 19 is consistent with the 
progressive narrowing of the ring lumens toward more proximal locations. The 
higher active and total forces of the LES could very simply be explained by 
an increase in the amount of circular muscle in this area. In fact, recent 
studies of formalin fixed stomachs taken from human cadavers have shown a 
distinctive thickening of muscle at the gastroesophagea1 junction, in an area 

- 34- 
that is thought to correspond with the in vivo LES. Thus, within the confines 
of this study, it is likely that the only intrinsic property of LES circular 
muscle that is distinctive with respect to adjacent muscles is its ability to 
develop tonus under basal resting conditions. 
The mechanism governing this basal tonus has received much attention, 
although not many concrete answers have resulted. The literature review and 
work of J. Fox, et al are summarized in part below. The LES of the North 
American opossum continuously exerts active tone that can be relaxed by field 
stimulation of nerves. This relaxation is not mediated by norepinephrine or 
a purine, and although prostaglandins may modulate this response, they do not 
appear to mediate it. Like other smooth muscles, LES contractions have been 
shown to be dependent on calcium. The peak force and maximal velocity of 
shortening are diminished by reducing the extracellular calcium concentration. 
LES tone is abolished after eliminating extracellular calcium. The work of 
J. Fox, et al suggested that the free intrace 11u1 ar calcium concentration 
responsible for producing tone was very dependent on the extracellular calcium 
concentration and a continuous membrane flux of calcium. There appear to be 
calcium-dependent action potentials in many smooth muscles which may result 
from activation of voltage-dependent conductance channels and allow entrance 
of extracellular calcium to maintain tone. If these calcium channels are 
always activated at normal membrane polarization, then this mechanism could 
25 
account for maintenance of LES resting tone. 
Comparison In Vitro Studies 
Having definedthe various forces generated by the LES and the differences 
between the LES and the adjacent esophageal muscle in the normal adult cat, 
this study compares these findings with those found in cats with esophagitis. 
Histologic damage was graded numerically to determine whether any changes 
noted were dependent on the degree of inflammation. 
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The passive forces generated by all rings tested, i.e. 2 distal through 
8 proximal, including the LES, with respect to the normal adult cats, were all 
roughly equivalent. The slightly higher passive forces generated by each suc¬ 
cessive proximal ring are due to the fact that each ring decreases in diameter 
as one moves from cardia to mid-esophagus. This is in accordance with the law 
of Laplace, where for a cylinder, luminal pressure = wall tension divided by 
the radius of the cylinder. Thus, for a given tension, i.e. the passive ten¬ 
sion, intraluminal pressure increases as the radius decreases. The law of 
Laplace also holds for those animals with esophagitis. The passive forces of 
these animals did not differ significantly from those of the normal controls. 
The passive force generated is thus purely a mechanical phenomenon and is in¬ 
dependent of histological damage secondary to acid infusion. 
The high basal force generated by the LES has been identified in this 
study as the only intrinsic property of LES circular muscle that is distinc¬ 
tive with respect to adjacent muscle. After induction of esophagitis, how¬ 
ever, the capacity of the LES to maintain a basal tonus which separates it 
from adjacent muscle is lost. This change was independent of the degree of 
histologic damage in that even those animals with relatively little inflamma¬ 
tion lost the capacity to produce a distinctive basal tone. The adjacent 
esophageal muscle showed no significant reduction in basal tonus after induc¬ 
tion of esophagitis. Thus, mucosal inflammation secondary to HC1 infusion 
abolished this intrinsic property of the LES to produce a high basal tone. 
It is possible that the inflammation directly or indirectly depletes the sup¬ 
ply of extracellular calcium or that hormonal controls regulating the membrane 
flux of calcium are altered by HCl-induced inflammation. 
The term "active force" is used to denote the maximum force of contrac¬ 
tion which is developed independently of the passive force. Depending on the 
stretch length, 80% of the active force at the LES can be basal-active force, 
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i.e. that force developed in physiologic solution exclusive of the passive 
force. The other 20% of this contractile force becomes important immediately 
after a swallow, with increased intra-abdominal pressure, with hormonal influ¬ 
ence, etc., as an important barrier to gastroesophageal reflux. After induc¬ 
tion of esophagitis, the active force generated by all rings is slightly, 
although not significantly, reduced except at the LES where the dramatic re¬ 
duction in active force is significant. Furthermore, the reduction in active 
force is directly proportional to the degree of histologic mucosal damage for 
all rings. This fact supports the hypothesis that the increase in active 
force by the LES with respect to adjacent rings is secondary to an increase 
in local muscle mass. In the LES, as in adjacent rings, an increase in the 
severity of the histologic damage leads to an increase in the amount of muscle 
rendered incapable of maintaining an active force. The deterioration of LES 
basal force with esophagitis, on the other hand, is independent of the degree 
of histologic mucosal damage. Further support of this hypothesis is uncov¬ 
ered in the finding that maximal active force development at the LES is also 
inversely proportional to the decree of mucosal inflammation. 
Artifactual changes observed in the muscularis propria were regarded as 
secondary to muscle bath manipulations. Previous studies by Higgs, et al 
observed normal light and electron microscopy of the muscularis propria after 
20 
experimental induction of esophagitis. Further studies to resolve any 
question of loss of muscle integrity will require that full thickness speci¬ 
mens be available for light and electron microscopic evaluation prior to in¬ 
troduction into muscle bath studies. 
In Vitro Indomethacin, Prostaglandin E2, and Prostaglandin F2aStudies 
In an attempt to define mediators and/or modulators of the inflammatory 
process of esophagitis, indomethacin and prostaglandins E2 and Fa were ad¬ 
ministered concurrently along with HC1 infusions. Prior to this study, there 
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had been no published in vitro data where cats with esophagitis were com¬ 
pared to similar cats treated with indomethacin, prostaglandin E2 or prosta¬ 
glandin F 2o< In vivo data, however, tended to support indomethacin as both 
maintaining resting LES pressure and decreasing the amount of mucosa damage 
created by artificial induction of esophagitis. The present study provides 
in vivo and in vitro evidence that neither indomethacin, prostaglandin E2, 
nor prostaglandin l2o< have any significant effect on either the degree of 
histologic damage produced or the change in total, active, basal, and basal- 
active forces generated after induction of esophagitis. As mentioned in the 
Discussion of the In Vivo Studies, technical explanations for this outcome 
include inadequate sample size for the prostaglandin groups, inadequate dos¬ 
ages, improper route of administration, etc. With respect to agent dosage 
and route of administration, however, each of these agents had been shown 
to have various effects on Gl muscle administered as such at these dosages 
in other studies. Also, each of these agents was shown to have a local ef¬ 
fect on the LES in the dose response studies. 
The sample size of the prostaglandin groups are small, but allowing for 
this, various trends are noted and warrant further investigation. The most 
obvious of these is that the LES active force of the group pre-treated with 
prostaglandin E2 is very similar to that of the non-acid control group and 
impressively higher than that of the acid control group. If one hypothesizes 
that protection of the mucosa, thereby diminishing inflammation enables the 
LES smooth muscle to generate stronger active contractions, then one could 
hypothesize that prostaglandin E2 is protecting the mucosa. E type prosta¬ 
glandins have been found to inhibit gastric acid secretion when given orally 
2 6 
and IV. Furthermore, this action has been attributed to a direct inhibi¬ 
tory effect on the parietal cell mass possibly mediated by inhibition of 
27 
gastrin release. These findings are usually the ones proposed as explana¬ 
tions for the anti-ulcer properties of prostaglandin E. However, recently 
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it has been shown that several prostaglandins, when given at doses much lower 
than their antisecretory dose, still protect gastric mucosal cells against 
injury and necrosis produced by strong irritants introduced into the gastric 
28 
lumen. Intestinal "cytoprotection" has also been demonstrated as 16, 16- 
Dimethyl prostaglandin E2 prevents the severe necrotic lesions of the ileum 
29 
produced in rats by high doses of prednisolone. The mechanism of "cyto- 
protection" is unknown. Some of the possibilities suggest that prostaglandin 
may cytoprotect by stimulating mucus secretion, by acting on the cyclic AMP 
system, by modifying the gastric mucosal circulation, or by strengthening 
cell membranes. Cytoprotective prostaglandin can be produced endogenously 
by the stomach.^ 
More directly applicable to the hypothesis that pros tag 1 andin E2 enables 
the LES to maintain some capacity for active contraction after esophagitis 
induction is the fact that prostaglandin actions are sensitive to calcium 
concentrations and to calcium-magnesium ratios. Prostaglandins may release 
bound calcium, and/or facilitate calcium fluxes, through the cell wall di- 
30 
rectly or secondarily through changes in intracellular cyclic AMP. The 
results of this study do not offer definite evidence in support of the 
theorized cytoprotective properties of prostaglandins. This study does sug¬ 
gest a trend in this direction and that further investigation of this area 
seems warranted, not in the field of prostaglandin inhibitory agents. 
3 
H-Thymidine Uptake Studies 
Patients with reflux esophagitis have been shown to have thickening of 
the basal zone of the esophageal squamous mucosa, as well as papillary elonga¬ 
tion. Accelerated cell turnover, as evidenced by an increase in the uptake of 
3 . 
H-thymidine, has been held responsible for this. This study, however, further 
defines these proliferative changes in two manners: 
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1. Proliferative change has been more clearly defined with respect to 
3 
time as H-thymidine mucosal uptake returned to normal or subnormal levels 
after a 3 week period. 
2. The mucosal area of maximum acid exposure shows a greater increase 
in cellular proliferation than adjacent areas with less acid exposure. One 
may speculate that repeated injury to the surface epithelium increases cell 
proliferation and migration to the surface to compensate for a greater rate 
of cell loss from the superficial epithelium. The thickening of the basal 
zone and the elongated papillae may be the morphological consequences of an 
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With "Dent Sleeve" in place, simultaneous readings of esophageal, 
LES, and gastric intraluminal pressures are shown. At approximately 
1 min into the recording, a swallow occurs exhibiting a rapid con¬ 
traction and rapid relaxation in the esophagus, an initial relaxa¬ 
tion followed by a sustained after-contraction by the LES, and es¬ 
sentially no change in gastric pressure. 
As in Figure 1, the "Dent Sleeve" is recording simultaneous esopha¬ 
geal, LES, and gastric intraluminal pressures. Two pairs of lines 
are drawn transecting each pressure recording such that simultaneous 
pressures from a given time period can be compared. As is shown, pres¬ 
sure increases with inspiration below the diaphragm while it decreases 
above the diaphragm, and decreases with expiration below the dia¬ 
phragm while it increases above the diaphragm. A swallow occurs 
toward the end of the recording. 
Main drawing shows an open abdomen displaying the stomach and distal 
esophagus with the one-hole probe in place and a needle placed at the 
high pressure point. The encircled drawing is a rough schematic of 
the fluoroscopic image showing the location of needle placement with 
respect to the probe which is also drawn in detail. A suture is 
placed at the needle location after fluoroscopy. 
The esophagus and stomach are shown (with the suture marking the high 
pressure area) mounted on a wax block and stretched to the measured 
in vivo length. The multiple razor blade cutting apparatus is dis¬ 








5. One of the 12 muscle baths which were operating simultaneously is 
displayed with an esophageal ring specimen stretched between the 
lower fixed hook and the upper hook which is attached to a force 
transducer. The transducer was moved up to increase stretch length. 
Not shown are a separate water jacket for temperature control and 
the mechanisms for filling and evacuating the chamber. 
6. The basic in vitro study is shown. The force generated by the ring 
is registered continually as it is bathed in tyrode, tyrode with KC1, 
and calcium-free tyrode with EDTA. After this, the ring is stretched 
and the cycle repeated. 
7 & 8. The change in in vivo LES pressure from its resting state is shown 
after administration of the noted drugs at the doses indicated. 
9. This is a summary of the in vivo data, showing the mean resting LES 
pressures of each group at days 1, 5, and 25 of the experimental 
period. The p values are given comparing the pre and post-esopha¬ 
gitis g roups. 
10. This is the graphic representation of Figure 9 showing the change in 
in vivo resting LES pressure during the experimental period for each 
of the 6 groups. There were no 3 week recovery studies done on the 
prostaglandin E2 and F2dgroups. 
11 - 16. For each ring specimen studied, i.e. 2 distal, LES, 2 proximal, 
4 proximal, 6 proximal, and 8 proximal, the total, basal, active, 
passive, and basal-active forces generated at each stretch length (12, 
24, 28, 30, 32, and 34 mm) are shown. The LES ring correponds to that 
ring containing the suture placed under fluoroscopy. These Figures 
represent the non-acid control group. 
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FIGURES 17 “ 21. Here, the same data in Figures 11 through 16 is presented dif¬ 
ferently. The ring specimens (HP or "high pressure" representing the 
LES, 8P representing the 8th ring proximal to the LES, etc.) are com¬ 
pared with one another for a given force production.In order, compari¬ 
sons in the development of basal, total, passive, active, and basal- 
active forces are presented. 
FIGURES 22. The mean maximal active force for each of the esophageal rings 
(8 proximal through 2 distal) is shown. 
FIGURE 23. Here is displayed the length at which the maximal active force is de¬ 
veloped by each esophageal ring specimen (8 proximal through 2 distal). 
FIGURES 24 - 29. These figures form the companion studies (after induction of 
esophagitis) to Figures 11 through 16. For each ring specimen studied, 
i.e. 2 distal through 8 proximal, the total, basal,active, passive, and 
basal-active forces generated at each stretch length (12, 24, 28, 30,32, 
and 3^ mm) are shown. 
FIGURES 30 - 33- Here are shown the basal, passive, basa1-active, and active 
forces generated by each of the rings tested (8 proximal through 2 
distal) both before and after induction of esophagitis, i.e. on days 
1 and 5 respectively. The graphs labeled "control" are identical to 
Figures 17, 19, 21, and 20 in order of appearance. The graphs labeled 
"esophagitis" are derived from the same data used to arrange Figures 
24 through 29- 
FIGURE 34. The maximal active force of each individual animal developed at the 
level of the LES (HP) and at the fourth proximal ring is shown by 
either a dot or square. Dots or squares connected by a line indicate 
that both rings come from the same animal. The 4 horizontal lines 
drawn in the midst of each sample represent that sample's mean maxi¬ 
mum active force. "Control" indicates the non-acid control group 
while "esophagitis" indicates the acid control group on day 5- 
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FIGURES 35 ~ 39- The purpose of these graphs is to correlate the degree of 
histologic damage secondary to HC1 infusion with maximum active force 
(MAF) production. In each graph, the control data (non-acid) is given 
for comparison with the acid control group on day 5 (labeled esopha¬ 
gitis) and for comparison with those cats of the acid control group 
with MAF greater than 7-85 as well as those with MAF less than 7-85- 
Passive, basal, total, active, and basal-active forces developed at 
the LES are displayed. An asterix designates those points on the 
force curves that differ significantly (p < .05) from the control 
points of identical stretch length. 
FIGURES 40 - 44. These are analagous to Figures 35 through 39 except that 
passive, basal, total, active, and basal-active forces developed 
A rings proximal to the LES are displayed. Again, the non-acid control 
group is compared with day 5 of the acid control group as well as with 
those of the acid control group with MAF > 7-85 and those with MAF 
< 7.85. The asterix shows those points that differ significantly 
(p < .05) from identical stretch lengths of the non-acid control 
animals. 
FIGURE 45. This graph displays the total, active, basal, passive, and basal- 
active forces developed at each stretch length (12, 24, 28, 30, 32, 
and 34 mm) by the LES of those cats in the high dose indomethacin 
group. 
FIGURE 46. Here, the mean basal, active, and total forces generated at a stretch 
length of 32 mm by the non-acid control group, the acid control group 
and the indomethacin (4 mg/kg) group are displayed for comparison. 
There was no significant (p < .05) difference between the acid control 






47. This graph displays the total, active, basal, passive, and basal- 
active forces developed at each stretch length by the LES of those 
cats in the pros tag 1 andin E2 group. 
48. This graph displays the total, active, basal, passive, and basal- 
active forces developed at each stretch length by the LES of those 
cats in the prostaglandin F2ci group. 
49. Here is shown the mean percentage of ->H-thymid ine labeled cells 
(from the bottom two layers of squamous mucosa) from suction biopsies 
at 2 cm and 4 cm proximal to the LES on days 1, 5, and 25. 
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DAY 1 DAY 5 
FIGURE 9 
DAY 25 
PRE-ACID POST-ACID POST-RECOVERY 
LES RESTING LES RESTING LES RESTING 
PRESSURE PRESSURE PRESSURE 
(mmHgtS.E.M.) (mmHg±S.E.N) (mmHq±S.E.M.) 
CONTROL 27.5* 3.7 b 7.5* 1.7 28.2*2.0 
LOW DOSE INDOCIN 20.0 ±1.5° 7.0* 1.3 37.0*5.0 
HIGH DOSE INDOCIN 20.4 ±2.8° 10.0*1.7 31.3*2.0 
flETOCLOPRAMIDE 26.5± 0.4 8.1 ±4.1 23.1*0.9 
PROSTAGLANDIN E2 23.4*2.8° 4.7* 1.7 
PROSTAGLANDIN F2D( 23.0±5.8C 4.5* l.l 
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- 3h - FIGURE UG 
IN VITRO FORCE COMPARISON 
AT A STRETCH LENGTH 
OF 32 mm 








NON-ACID CONTROL 3 123*1.3 103*1.1 16.2*1.6 
ACID CONTROL 12 5.7*12 6.3*03 103*1.5 
INDOCIN (Wkg) 6 6.1*1.6 83*03 11.5*2.3 
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